Comparison Of Clinical And Patient Reported Outcomes In Patients With Glaucoma Implanted With An Enhanced Or A Standard Monofocal Iol
Published 2024 - 42nd Congress of the ESCRS
Reference: PP13.01 | Type: Free paper | DOI: 10.82333/4kvn-s383
Authors: Stephen Hannan* 1 , Sandro DiSimplicio 1 , David Teenan 1 , Jan Venter 1
1Optical Express,Glasgow,United Kingdom
Purpose
To compare the clinical and patient reported outcomes of TECNIS Eyhance (ICB) monofocal intraocular lens (IOL) to a standard TECNIS One (ZCB) monofocal IOL in a sample of patients with Glaucoma.
Setting
Private Refractive Surgery (Optical Express)
Methods
Stable Primary Open Angle Glaucoma patients with moderate visual field defect, who underwent intraocular surgery with either TECNIS Eyhance (ICB) monofocal IOL, n=52 patients, 84 eyes, or TECNIS One (ZCB) monofocal IOL, n=133 patients, 193 eyes, were analyzed. Both cohorts were well matched based on demographic and preoperative parameters. Patient age range was 48 to 98 years, with a preop refractive range of +6.50D to -11.00D sphere and up to -1.75D of astigmatism. Postoperative clinical safety and efficacy outcomes up to 12 months, with a mean of 3 months, following implant were analyzed.
Results
UCDVA 20/20 or better achieved in 64% ICB patients, 59% ZCB (p>0.05). 94% ICB and 93% ZCB reached 20/40 or better (p>0.05). UCIVA 20/40 or better 79% in ICB, 39% ZCB (p<0.01). UCNVA N8 or better in 40% ICB, 20% ZCB (p<0.01). 3% of ICB eyes had loss >2 lines BCVDA, 0% ZCB (p=0.02). Mean difference between postop UCDVA and BCVDA was <1 line for both cohorts (p>0.05). Intended vs achieved SE ±0.5D was 93% for ICB, 80% ZCB (p=0.02); ±1.0D was 99% and 95% (p>0.05). Intended vs achieved cylinder ±0.5D was 71% ICB and 50% ZCB (p<0.01); ±1.0D was 94% and 87% (p>0.05). Patient satisfaction was >90% for both cohorts (p>0.05). QOV was comparable between cohorts (p>0.05).
Conclusions
The TECNIS Eyhance provides a safe and effective monofocal IOL option for Stable Primary Open Angle Glaucoma patients. UCDVA performance is comparable to a standard monofocal lens at distance with meaningful improvements to UCIVA and UCNVA. The loss of > 2 lines BCDVA is impacted upon by both the small sample size and posterior capsular opacification. Patient reported satisfaction is also high postoperatively for TECNIS Eyhance, as with TECNIS One (ZCB) IOL.